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Background: A variety of anesthetic techniques have been used to make transvaginal oocyte retrieval (TVOR) safe and 
efficient. The optimal anesthetic technique during TVOR should provide safe, effective analgesia, few side effects, a short 
recovery time, and be nontoxic to the oocytes that are being retrieved. The concept of conscious sedation is widely accepted 
for the short‑term management of pain.
Objective: This study assessed patient’s perception of pain using conscious sedation and in‑vitro fertilization (IVF) outcomes.
Materials and Methods: A cross sectional study of 71 eligible patients that underwent assisted reproduction program in our 
facility. All clients were treated with antagonist protocol for controlled ovarian hyperstimulation. Self‑administered questionnaires 
were used as the research instrument. Pain was assessed using a 10 cm visual analogue scale (VAS), while client’s overall 
satisfaction was rated using Likert scoring system.
Results: Client aged 33.2 ± 4.2 years. Most of them had primary infertility with mean duration of 4.5 ± 2.9 years. Unexplained 
infertility was the commonest cause of infertility. The pregnancy rate per embryo transfer was 47.9%, miscarriage rate was 
5.6%, while the live birth rate was 42.3%. The mean VAS scores at 1 h, 6 h, 24 h and at embryo transfer were 4.9 ± 1.7, 
2.5 ± 1.2, 1.3 ± 0.9, and 0.5 ± 0.6, while the Likert score was 3.8 ± 1.1.
Conclusion: Conscious sedation with Midazolam and Pethidine is a safe, effective, and acceptable method of analgesia/
anesthesia for TVOR. However randomized prospective studies with larger sample sizes are recommended.
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Introduction
Oocyte retrieval is one of the fundamental steps in in-vitro 
fertilization/embryo transfer (IVF/ET) treatment. It was 
previously done through laparoscopy but is now being 
done less invasively through the vagina with the aid of an 
ultrasound scan.[1,2] TVOR may be the most painful procedure 
performed during IVF/ET treatment.[3]
A variety of anesthetic techniques have been used to make 
TVOR safe and efficient.The optimal anesthetic technique 
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during TVOR should provide safe, effective analgesia, few 
side effects, a short recovery time, and be nontoxic to the 
oocytes that are being retrieved.[3,4]
Types of pain relief used for TVOR include conscious sedation, 
local, epidural, spinal and general anaesthesia. General 
anesthetic agents traverse easily into follicular fluid and may 
have detrimental effects on cleavage rates of embryos and 
pregnancy rates, and as such are not popular in IVF.[2] The 
concept of conscious sedation is widely accepted for the 
short-term management of pain, defined as a technique 
in which the use of a drug or drugs produces a state of 
depression of the central nervous system enabling treatment 
to be carried out, but during which verbal contact with the 
patient is maintained throughout the period of sedation.[5] It 
is the most common methodof pain relief used for TVOR by 
IVF units worldwide.[2]
Studies suggest higher pregnancy and delivery rates if 
conscious sedation or epidural anesthesia is used instead 
of general anesthesia.[2,5] We present our experience with 
conscious sedation for TVOR on clients’ pain perceptions 
and IVF outcomes
Materials and Methods
This is a cross-sectional study of 71 eligible clients’ that 
underwent assisted conception program (IVF/ICSI) at the 
assisted reproductive technology (ART) unit of university 
of Ilorin teaching hospital, Ilorin between 1st January 
2013 and 31st December 2017. Investigation results, 
i.e. transvaginal/saline infusion sonography, hormonal 
profile, and/or laparo-endoscopic findings were noted and 
necessary interventions were instituted prior to recruitment. 
Information on bio-social variables, gender factor infertility, 
types of stimulation protocols, duration of FSH used/dosage, 
endometrial thickness at embryo transfer, types of anaesthesia/
analgesia used for oocyte retrieval, visual analogue scale (VAS) 
at 1 h, 6 h, 24 h and on the day of embryo transfer, Likert score 
and pregnancy outcomes were properly documented.
Clients’ were counseled on conscious sedation for TVOR. 
Informed consent was obtained from each patient and 
protection of personal data and confidentiality were prioritized. 
Inclusion criteria were normo-responders (age < 40 years), 
clients’ with normogonadotrophic normogonadism, first 
attempt at TVOR and those consented to participate in the 
study while the exclusion criteria included clients’ who were 
allergic to general anesthetic agents, with cardiopulmonary 
compromise, thyroid dysfunction, whose TVOR exceeded 
more than one hour and those that required other forms of 
analgesia for pain relief during TVOR.
Seminal fluid analysis was conducted for male partners. The 
criteria for men were a sperm count of at least 20 million cells 
per milliliter of semen and progressive sperm motility of 50% 
or greater. Male partners with semen count and/or motility 
less than the cut-off values were offered intracytoplasmic 
sperm injection (ICSI) unless the sperm count was zero after 
centrifugation in which case donor sperm was used for in vitro 
fertilization.
All clients had a body mass index (BMI) (calculated as weight in 
kilograms divided by the square of height in meters) ranging 
between 18 and 30 with a mean of 24 ± 4 Kg/m2. All had 
antagonist protocol for controlled ovarian hyperstimulation. 
Their infertility evaluation results were normal. Also, all had 
oral contraceptive pills for menstrual cycle synchronization 
and pre-cervical assessment (trial/dummy transfer) on day 2/3 
of menses prior to commencement of stimulation.
Stimulation protocol
Clients were commenced on 150 IU (2vials) of recombinant FSH 
Gonal F (Gonal F®; Merckserono, Germany) and 75 IU (1 vial) 
highly purified FSH (Folliculin®; Barrat pharmaceutical, India) 
on day 3 of menstrual cycle for 11–14 days. Transvaginal 
ultrasonographic scan was also done at intervals from day 
5/6 of stimulation to determine the numbers, size of follicles, 
and endometrial thickness. Subcutaneous 2.5 mg daily 
GnRH antagonist (Cetrotide®; merckserono, Germany) was 
administered whenever the follicles have grown to 14 mm 
size usually around day 6/7 of stimulation and was continued 
till the day of trigger to prevent premature LH surge. In total 
83 µg (83µg [2000IU]) of recombinant human chorionic 
gonadotrophin (hCG: Ovitrelle; merckserono, Germany) and 
0.25mg of buserelin (Supricure®; Aventis Pharm, West Malling, 
UK) were administered subcutaneously for trigger whenever 2 
or more follicles have grown to 18mm or more and oocyte 
retrieval was carried out at 35.5 h thereafter.
Anaesthesia/analgesia for oocyte retrieval
All clients were counseled to fast overnight and 1 mg of 
Atropine was administered intravenously as pre-anaesthetic 
medication. Conscious sedation was achieved with 
50 mg of Pethidine and 2.5 mg of Midazolam administered 
intravenously. Sedation was adjusted with 50 mg increments 
of Pethidine and/or 2.5 mg of Midazolam based on clinician 
perception of client’s response to pain in the course of TVOR 
to a maximum dose of 200 mg and 10 mg for Pethidine and 
Midazolam respectively over an hour period.
Oocyte retrieval, insemination, embryo transfer and 
luteal phase
TVOR was done at 35.5 h of hCG injection with the aid 
of 17G needle (Origio®, Denmark) and the aspirate in a 
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test tube was transferred immediately to the laboratory 
for oocyte screening and pickup. Mature oocytes were 
inseminated with prepared sperm after six (6) hours of 
oocyte pickup and incubated. ICSI was done in cases 
of severe male factor infertility. Best cleavage embryos 
were transferred on day 5 of oocyte retrieval usually at 
the blastocyst stage under trans-abdominal ultrasound 
guidance and the transfer catheters were checked to 
ensure all the embryos were transferred. The number of 
embryos transferred was individualized, 2 or 3 in most 
cases. The luteal phase support was conducted with 
progesterone (800 mg twice daily [cyclogest pessaries®; 
Cox, Brarnstaple, UK] and Intramuscular 100 mg twice 
weekly [Gestone®;Ferring, pharmaceutical, Mumbai, India]). 
Serum pregnancy test was carried out two weeks after 
embryo transfer and subsequently transvaginal ultrasound 
scan at 6th weeks for detection of gestational sac and/or 
viability of the fetus.
Visual analog scale and Likert score
Following TVOR, clients had self-administered questionnaires 
administered to assess their perception of pain using VAS 
scoring system[6] on a scale of (0-10cm) at 1 h, 6 h, 24 h, and on 
the day of embryo transfer respectively and their responses 
were properly documented. VAS scoring was graded as 0- no 
pain, 1-3 – mild pain, 4-6 – moderate pain and 7-10 – severe 
pain. Also overall clients’ satisfactions were assessed through 
Likert scoring system[7] on a scale of (1-5) categorized as 
1- poor, 2- fair, 3- satisfactory, 4- very good and 5- Excellent.
Statistical analysis
Statistical analysis was done using Epi-info version 7.1.3.0 
(Centres for Disease Control and Prevention-CDC, Atlanta, 
USA), Categorical data were expressed as numbers and 
percentages while numerical data were expressed as mean 
and standard deviation. Associations of categorical variables 
were tested using Chi square test, while statistical significance 
was set at P ≤	0.05.	Results	were	presented	in	tables.
Results
Table 1 shows the characteristics of the women undergoing 
IVF-ET and their spouses. The mean age of the women and 
their spouses were 33.2 ± 4.2 years and 38.7 ± 4.5 years 
respectively. The mean duration of infertility was 
4.5 ± 2.9 years. Most (52.9%) of the couple had primary 
infertility while unexplained infertility was the commonest 
cause of infertility (39.4%).
The mean duration of FSH, Mean FSH ampoule used 
and endometrial thickness were 13.7 ± 1.8, 32.6 ± 5.2 
and 8.6 ± 2.0 respectively.The mean number of oocyte 
retrieved and mean number of oocyte fertilized were 
11.4 ± 5.5 and 7.3 ± 3.5 respectively [Table 2]. The 
clinical pregnancy rate per embryo transferred was 47.9%, 
miscarriage rate was 5.6%, while the live birth rate was 
42.2% [Table 3].
Table 4 shows clients’ perception of pain and satisfaction. The 
mean VAS scores at 1hour, 6 h, 24 h and at embryo transfer 
were 4.9 ± 1.7, 2.45 ± 1.2, 1.3 ± 0.9 and 0.5 ± 0.6. The 
mean Likert score was 3.8 ± 1.1
Table 1: Socio-demographic characteristics































Male factor 11 15.5
Female factor 18 25.4
Male/female factor 14 19.7
Unexplained 28 39.4
Table 2: Stimulation cycle characteristics of the clients
Variables Mean
Duration of FSH (days) 13.7±1.8
FSH ampoule used 32.6±5.1
Endometrial thickness 8.6±2.0
No. of oocyte retrieved 11.4±5.5
No. of oocyte fertilized 7.43±3.51
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Discussion
In this study, the mean age of the clients and the mean 
number of oocytes retrieved were 33.2 ± 4.2 and 11.4 ± 5.5. 
This is in consonance with the mean age of 33.7 ± 4.9 and 
mean number of oocytes retrieved of 13.31 ± 9.04 obtained 
in a previous study in Nigeria.[2]Also, unexplained infertility 
was the commonest cause of infertility in our series. On the 
contrary combined male and female factors predominate 
in an earlier study at Tamil, India.[6] However, varied 
geographical locations of both studies could be responsible 
for the difference.
The clinical pregnancy rate of 47.9% is comparable to 40.7% 
recorded in a similar study in India.[6] However, there are 
controversies regarding the effects of anaesthetic agents 
administered during TVOR onfertilization, embryonic 
development and conception rate.[7-9] Some anaesthetic drugs 
mostespecially halogenated agents have been found in the 
follicular fluid and these could have deleteriouseffects on 
the oocyte and/or follicular structures, thereby interfering 
with the Reproductive process,[7,10,11] conversely, conscious 
sedation (opiods in combination with Benzodiazepines) 
which wasemployed in our series was reported to be a safe, 
well tolerated and cost effective method of anaesthesia for 
oocyteretrieval devoid ofinterference with reproductive 
process.[12-15] These couldbe responsible for the clinical 
pregnancy rate of 47.9% reported in this study. However, no 
single method of anaesthesia/analgesia for TVOR appeared 
superior for pregnancy rates and pain relief asobserved in a 
randomized controlled trial.[5] Thus the need for a multimodal 
approach to anaesthesia/analgesia for oocyte retrieval.
The mean VAS scores at 1 h, 6 h, 24 h and at embryo transfer 
of 4.9 ± 1.7, 2.5 ± 1.2,1.3 ± 0.9, and 0.5 ± 0.6 were 
comparable with 2.8 ± 1.7, 0.78 ± 1.04, 0.39 ± 1.09, 
and 0.14 ± 0.58, respectively obtained in a similar study at 
Tamil Nadu India.[6]Similarly, Fiebai et al. inNigeria reported 
a one-point post TVORlow mean VAS score of 3.89 ± 1.98 
following use ofconscious sedation (Midazolam and 
Pethidine) with most clients expressing satisfaction and 94% 
indicating a preference for it in any subsequent procedure.[2]
In this study over all clients’ satisfaction was assessed using 
Likert scoring system. The mean Likert score of (3.8 ± 1.1) 
ranging between satisfactory and very good is in keeping 
with findings from a similar study in Tamil Nadu, India that 
reported a meanlikert score of (3.6 ± 0.8) with high clients’ 
satisfaction and acceptance of Midazolam and Pethidine 
combination for TVOR.[6]
Conclusion
Conscious sedation with Midazolam and Pethidine is a safe, 
effective and acceptableanalgesia/anaesthetic option for 
transvaginal oocyte retrieval. Randomized controlled trials on 
variedcombination of medications for conscious sedation and 
by extension a multimodal approach ofanalgesia/anaesthesia 
for transvaginal oocyte retrieval is recommended to further 
improve on clientssatisfaction.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
1. Sharma A, Borle A. Review article anaesthesia for in vitro fertilization. 
J Obstet Anaesth Crit Care 2015;5:62-72.
2. Fiebai PO, Ogunmokun AA, Ajayi RA. Experience with Conscious 
sedation for oocyte retrieval in Nigeria. Afr Reprod Health 2008;12:30-4.
3. Atakoshii S, Abdollahi S, Dejani A, Farzadi L. Conscious sedation with 
and without paracervical block for transvaginal ultrasonicaly guided 
oocyte collection: A comparison of the pain and sedation levels and 
postoperative side effects. Iran J Reprod Med 2006;4:51-6.
4. Elnabtity AMA, Selim MF. A prospective randomized trial comparing 
Dexmedetomidine and Midazolin for conscious sedation during oocyte 
retrieval in an in vitro fertilization program. Anaesth Essays Res 
2017;11:34-9.
5. Kwan I, Bhattacharya S, Kno F, McNeil A. Conscious sedation and 
analgesia for oocyte retrieval during IVF procedures: Acochrane review. 
Hum Reprod 2006;21:1672-9.
6. Singhal H, Premkumar PS, Chandy A, Kunjummen AT, Kamath MS. 
Patient experience with conscious sedation as a method of pain relief for 
transvaginal oocyte retrieval: A cross sectional study. J Hum ReprodSci 
2017;10:119-23.
7. Wilhelm W, Hammadeh ME, White PF, Georg T, Fleser R, Bieder A. 
General anesthesia versus monitored anesthesia care with remifentanil 
for assisted reproductive technologies: Effect on pregnancy rate. J Clin 
Anesth 2002;14:1-5.
8. Gonen O, Shulman A, Ghetler Y, Shapiro A, Judeiken R, 
Beyth Y. The impact of different types of anesthesia on in vitro 
fertilization-embryo transfer treatment outcome. J Assist Reprod 
Genet 1995;12:678-82.
Table 3: Clinical outcomes
Outcome Frequency (n=71) Percentage
Clinical Pregnancy 34 47.9
Miscarriage rate 4 5.6
Live birth rate 30 42.3
Table 4: Clients’ perception of pain and satisfaction
VAS score Mean
VAS at 1 h 4.9±1.7
VAS at 6 h 2.5±1.2
VAS at 24 h 1.3±0.9
VAS at ET 0.5±0.6
Likert 3.8±1.1
Omokanye, et al.: Anesthesia for oocyte retrieval
155Tropical Journal of Obstetrics and Gynaecology / Volume 37 / Issue 1 / January-April 2020
9. Casati A, Valentini G, Zangrillo A, Senatore R, Mello A, Airaghi B, 
et al. Anaesthesia for ultrasound guided oocyte retrieval: Midazolam/
remifentanil versus propofol/fentanyl regimens. Eur J Anaesthesiol 
1999;16:773-8.
10. Imoedemhe DA, Sigue AB, Abdul-Ghani I, Abozeid MA, 
Abdel Halim MS. An evaluation of the effect of the anesthetic agent 
propofol (Diprivan) on the outcome of human in vitro fertilization. 
J Assist Reprod Genet 1992;9:488-91.
11. Boyers SP, Lavy G, Russell JB, DeCherney AH. A paired analysis 
of in vitro fertilization and cleavage rates of first- versus last 
recovered preovulatory human oocytes exposed to varying interval 
of 100% CO2-pneumoperitoneum and general anesthesia. FertilSteril 
1987;48:969-74.
12. Trout SW, Vallerand AH, Kemmann E. Conscious sedation forin 
vitrofertilization. FertilSteril 1998;69:799-808.
13. Soussis I, Boyd O, Paraschos T, Duffy S, Bowers S, TroughtonP, 
et al. Follicular fluid levels ofmidazolam, fentanyl, and alfentanil 
duringtransvaginal oocyte retrieval. FertilSteril1995;64:1003-7.
14. Ben-Shlomo I, Moskovich R, Katz Y, Shaley E. Ivlidazolam/ketamine 
sedative combination compared with fentanyl/propofol/isoflurane 
anesthesia for oocyte retrieval. Hum Repord 1999;14:1757-9.
15. Chapineau J, Bazin JE, Terrisse MP, Sautou V, Janny L, Schoeffler P, 
et al. Assay for midazolam in liquor follicular during invitro fertilization 
under anaesthesia. ClinPharm 1993;12:770-3.
